Solid Tumor Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 08
SKU : PH457
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
How big is the Solid Tumor Therapeutics Market ?
Global Solid Tumor Therapeutics Market reached USD 194.1 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 565.6 million by 2031.
Who are the Key Players of Solid Tumor Therapeutics Market ?
The major global players in the market include Sanofi, Amgen Inc., AstraZeneca PLC, Baxter International Inc., Biogen Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, and GlaxoSmithKline PLC among others.
Related Reports
pharmaceuticals

Xerostomia Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 17
Starting from

$4350

pharmaceuticals

Scleroderma Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 17
Starting from

$4350

pharmaceuticals

Leukemia Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 05
Starting from

$4350

pharmaceuticals

Rosacea Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 09
Starting from

$4350

pharmaceuticals

Pneumonia Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 11
Starting from

$4350

pharmaceuticals

Eczema Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 02
Starting from

$4350